XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Investments    
Investment in related party investment fund, at fair value $ 397,888 $ 258,890
Other investments 73,559 73,293
Total investments 471,447 332,183
Cash and cash equivalents 54,642 51,082
Restricted cash and cash equivalents 567,091 604,648
Reinsurance balances receivable (net of allowance for expected credit losses of 2024: $865 and 2023: $854) 718,719 619,401
Loss and loss adjustment expenses recoverable (net of allowance for expected credit losses of 2024: $700 and 2023: $487) 65,947 25,687
Deferred acquisition costs 82,206 79,956
Unearned premiums ceded 35,270 17,261
Other assets 6,364 5,089
Total assets 2,001,686 1,735,307
Liabilities    
Loss and loss adjustment expense reserves 811,152 661,554
Unearned premium reserves 347,103 306,310
Reinsurance balances payable 88,152 68,983
Funds withheld 20,788 17,289
Other liabilities 8,491 11,795
Debt 62,582 73,281
Total liabilities 1,338,268 1,139,212
Commitments and Contingencies (Note 15)
Shareholders' equity    
Preferred share capital (par value $0.10; none issued) 0 0
Ordinary share capital (par value $0.10; issued and outstanding, 34,832,493) (2023: par value $0.10; issued and outstanding, 35,336,732) 3,483 3,534
Additional paid-in capital 481,672 484,532
Retained earnings 178,263 108,029
Total shareholders' equity 663,418 596,095
Total liabilities and equity $ 2,001,686 $ 1,735,307